Anna Arnoldi Selected Research

Isoflavones

10/2008	Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
1/2007	Soy protein diet improves endothelial dysfunction in renal transplant patients.
1/2005	A simple method for the characterization and quantification of soy isoflavone metabolites in the serum of MMTV-Neu mice using high-performance liquid chromatography/electrospray ionization mass spectrometry with multiple reaction monitoring.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Arnoldi Research Topics

Disease

7	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 01/2004
5	Hypercholesterolemia 11/2019 - 01/2003
4	Inflammation (Inflammations) 01/2022 - 01/2007
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2009
3	Atherosclerosis 03/2009 - 01/2005
2	Hypertension (High Blood Pressure) 10/2019 - 12/2009
2	Dyslipidemias (Dyslipidemia) 01/2014 - 03/2009
2	Breast Neoplasms (Breast Cancer) 10/2008 - 01/2005
2	Neoplasms (Cancer) 10/2008 - 01/2005
1	COVID-19 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Pathologic Processes 10/2019
1	Body Weight (Weight, Body) 03/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2016
1	Carcinogenesis 10/2008
1	Neoplasm Metastasis (Metastasis) 10/2008
1	Hyperlipidemias (Hyperlipidemia) 06/2005
1	Hepatocellular Carcinoma (Hepatoma) 01/2004

Drug/Important Bio-Agent (IBA)

7	Peptides (Polypeptides)IBA 04/2022 - 10/2008
6	Proteins (Proteins, Gene)FDA Link 12/2016 - 06/2005
4	LipidsIBA 03/2018 - 01/2004
3	IsoflavonesIBA 10/2008 - 01/2005
2	Biological ProductsIBA 01/2022 - 10/2008
2	CholesterolIBA 01/2014 - 12/2009
2	Soybean Proteins (Soy Protein)IBA 10/2008 - 01/2003
2	Phytoestrogens (Phytoestrogen)IBA 01/2005 - 01/2005
1	PeptidomimeticsIBA 04/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	EpitopesIBA 01/2022
1	AntioxidantsIBA 01/2021
1	Chelating AgentsIBA 01/2021
1	Protein Hydrolysates FDA Link 10/2019
1	Apolipoproteins B (ApoB)IBA 03/2018
1	oxidized low density lipoproteinIBA 03/2018
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2016
1	Proprotein Convertase 9IBA 01/2016
1	red yeast riceIBA 01/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2014
1	astaxanthine (astaxanthin)IBA 01/2014
1	coenzyme Q10 (CoQ10)IBA 01/2014
1	policosanolIBA 01/2014
1	BerberineIBA 01/2014
1	Tocopherols (Tocopherol)IBA 08/2011
1	PhytochemicalsIBA 08/2011
1	Dietary ProteinsIBA 03/2009
1	Bromodeoxyuridine (BrdU)IBA 10/2008
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2008
1	Reducing AgentsIBA 10/2008
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2007
1	Lipid PeroxidesIBA 01/2007
1	Arginine (L-Arginine)FDA Link 01/2007
1	GenisteinIBA 01/2007
1	daidzeinIBA 01/2007
1	C-Reactive ProteinIBA 01/2007
1	LDL CholesterolIBA 06/2005
1	Hormones (Hormone)IBA 01/2005
1	PolyphenolsIBA 01/2005
1	Plant ProteinsIBA 01/2004
1	LDL Receptors (LDL Receptor)IBA 01/2004

Therapy/Procedure

1	Therapeutics 01/2021
1	Secondary Prevention 03/2009